David Einhorn: portfolio of Greenlight Capital

David Einhorn leads Greenlight Capital, which follows a value approach; short sales do not appear in the 13F report.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

3.6B USDQ3 2026
Total value of stock positions
3.6B USD
Positions
45
Share of the ten largest
52.5%

The ten largest positions Q3 2026

  1. Green Brick Partners Inc 17.6%unchanged
  2. Fluor Corp 6.2%▼ −1.1%
  3. Core Natural Resources Inc 5.5%▼ −1.2%
  4. Versigent PLC 4.1%▲ +41.4%
  5. Brighthouse Finl Inc 4.0%unchanged
  6. PG&E Corporation 3.4%▲ +50.8%
  7. Acadia Healthcare Company In 3.4%unchanged
  8. Centene Corporation 2.9%unchanged
  9. Dht Holdings Inc 2.7%▼ −15.0%
  10. Dauch Corp 2.7%▲ +48.5%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 8.0B USD).
Choose a quarter (54 filings)

All positions Q3 2026

Positions Q3 2026 per 13F filing, 45 of 45
Symbol Weight Shares Reported value Change Held since
Green Brick Partners Inc 17.6% 9,467,383 625.9M USD unchanged Q4 2014 48 quarters
Brighthouse Finl Inc 4.0% 2,842,100 141.8M USD unchanged Q3 2017 37 quarters
SPDR Gold TR 1.0% 92,281 35.1M USD +10.6% increased Q2 2020 26 quarters
Gain Therapeutics Inc < 0.1% 566,130 979.4K USD unchanged Q1 2021 23 quarters
Nuvation Bio Inc < 0.1% 34,995 196.0K USD unchanged Q1 2021 23 quarters
Graphic Packaging Hldg Co 2.5% 9,953,430 90.1M USD unchanged Q2 2021 22 quarters
Lakefront Biotherapeutics NV 0.4% 482,746 14.3M USD unchanged Q4 2021 20 quarters
Coya Therapeutics Inc 0.3% 2,335,540 11.7M USD unchanged Q4 2022 16 quarters
Dht Holdings Inc 2.7% 4,281,242 96.6M USD −15.0% reduced Q3 2023 13 quarters
Penn Entertainment Inc 2.4% 5,923,010 86.8M USD +1.1% increased Q1 2024 11 quarters
Liberty Global Ltd 1.3% 4,963,322 45.3M USD unchanged Q1 2024 11 quarters
Roivant Sciences Ltd 1.2% 1,131,747 41.4M USD −47.4% reduced Q1 2024 11 quarters
Capri Holdings Limited 1.9% 4,820,118 68.1M USD unchanged Q2 2024 10 quarters
Cnh Indl N V 1.5% 4,188,940 53.8M USD unchanged Q3 2024 9 quarters
Acadia Healthcare Company In 3.4% 4,400,641 121.0M USD unchanged Q4 2024 8 quarters
CNC Centene Corporation 2.9% 1,651,150 102.6M USD unchanged Q4 2024 8 quarters
TD Synnex Corporation 2.3% 313,856 80.6M USD −17.6% reduced Q4 2024 8 quarters
Core Natural Resources Inc 5.5% 2,255,990 193.7M USD −1.2% reduced Q1 2025 7 quarters
Fluor Corp 6.2% 4,607,666 220.6M USD −1.1% reduced Q2 2025 6 quarters
Sotera Health Co 1.7% 3,241,725 59.9M USD −21.6% reduced Q2 2025 6 quarters
CI Cigna 0.7% 88,400 24.0M USD unchanged Q2 2025 6 quarters
PCG PG&E Corporation 3.4% 10,000,000 122.5M USD +50.8% increased Q3 2025 5 quarters
Bkv Corp 2.0% 3,322,043 70.9M USD +7.3% increased Q4 2025 4 quarters
HSIC Henry Schein 1.7% 718,550 60.3M USD unchanged Q4 2025 4 quarters
Antero Resources Corp 1.5% 1,550,800 51.8M USD −1.5% reduced Q4 2025 4 quarters
DECK Deckers Brands 1.1% 506,398 39.6M USD unchanged Q4 2025 4 quarters
Slide Ins HLDGS Inc 0.8% 1,349,304 30.1M USD −20.0% reduced Q4 2025 4 quarters
Dauch Corp 2.7% 18,411,629 96.1M USD +48.5% increased Q1 2026 3 quarters
Crocs Inc 2.2% 653,800 76.7M USD −2.3% reduced Q1 2026 3 quarters
VTRS Viatris 2.1% 4,294,920 76.1M USD +54.9% increased Q1 2026 3 quarters
Versant Media Group Inc 2.0% 2,275,842 72.1M USD +18.4% increased Q1 2026 3 quarters
Immunovant Inc < 0.1% 70,140 2.4M USD −25.0% reduced Q1 2026 3 quarters
Resideo Technologies Inc < 0.1% 103,277 1.9M USD −93.9% reduced Q1 2026 3 quarters
Versigent PLC 4.1% 3,220,500 144.7M USD +41.4% increased Q2 2026 2 quarters
Fortune Brands Innovations I 2.4% 2,275,255 86.6M USD +1.5% increased Q2 2026 2 quarters
CMCSA Comcast 1.7% 2,823,060 61.4M USD +109.8% increased Q2 2026 2 quarters
Primo Brands Corporation 1.5% 2,823,660 53.8M USD unchanged Q2 2026 2 quarters
Pvh Corporation 1.1% 520,800 38.6M USD unchanged Q2 2026 2 quarters
Century Alum Co 2.3% 2,270,936 81.7M USD new Q3 2026 1 quarter
Teva Pharmaceutical Inds Ltd 2.0% 1,817,146 72.0M USD new Q3 2026 1 quarter
Sl Green Rlty Corp 1.5% 1,063,220 52.0M USD new Q3 2026 1 quarter
Adi Global Distr Inc 1.3% 2,599,954 46.6M USD new Q3 2026 1 quarter
Bio Rad Labs Inc 1.1% 103,990 39.3M USD new Q3 2026 1 quarter
MGM MGM Resorts 1.0% 1,098,270 34.1M USD new Q3 2026 1 quarter
Lkq Corp 0.8% 1,204,170 27.5M USD new Q3 2026 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Health Care 7.4%
  • Utilities 3.4%
  • Consumer Discretionary 2.1%
  • Communication Services 1.7%
  • not in our coverage 85.3%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

Follow as a favorites list

With a free account you can turn the 8 stocks of this portfolio that we cover into your own favorites list.

Add to a favorites list Log in

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close